| 000 | 01755 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515211544.0 | ||
| 264 | 0 | _c20100922 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1568-5608 | ||
| 024 | 7 |
_a10.1007/s10787-010-0036-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGraham, Garry G | |
| 245 | 0 | 0 |
_aFDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable? _h[electronic resource] |
| 260 |
_bInflammopharmacology _cApr 2010 |
||
| 300 |
_a47-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetaminophen _xadministration & dosage |
| 650 | 0 | 4 | _aAdvisory Committees |
| 650 | 0 | 4 |
_aAlcohol Drinking _xadverse effects |
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xprevention & control |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aDrug Labeling _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug Packaging _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aDrug and Narcotic Control |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNonprescription Drugs _xadministration & dosage |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 |
_aPrescription Drugs _xadministration & dosage |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aDay, Richard O | |
| 700 | 1 | _aGraudins, Andis | |
| 700 | 1 | _aMohamudally, Anthoulla | |
| 773 | 0 |
_tInflammopharmacology _gvol. 18 _gno. 2 _gp. 47-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10787-010-0036-6 _zAvailable from publisher's website |
| 999 |
_c19580392 _d19580392 |
||